Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 40

Sort by

Sort Order Select

Journal Articles

Increased Levels Of Tissue Factor, Adhesion Molecules, Nitric Oxide and Adiponectin In End Stage Renal Disease. A Complex Interplay

Jawed Fareed, Ph.D., Kristiyana Kaneva, Debra Hoppensteadt, Ph.D., Vinod Bansal, MD

Blood (2013) 122 (21): 4742.

https://doi.org/10.1182/blood.V122.21.4742.4742

Published: 2013

Journal Articles

Effect Of Purified Poloxamer 188 and Various Dextrans On Erythrocyte Sedimentation Rate In Healthy Subjects and Patients With Sickle Cell Disease

Debra Hoppensteadt, Ph.D., Martin Emanuele, PhD, Joann Molnar, BS, Omer Iqbal, MD, Jawed Fareed, Ph.D.

Blood (2013) 122 (21): 4764.

https://doi.org/10.1182/blood.V122.21.4764.4764

Published: 2013

Journal Articles

Comparative Studies Of Purified Poloxamer 188 Using ClotBased and Viscoelastic Measurements Of Coagulation

Jawed Fareed, Ph.D., Debra Hoppensteadt, Ph.D., Omer Iqbal, MD, Schuharazad Abro, MD, Martin Emanuele, PhD

Blood (2013) 122 (21): 4770.

https://doi.org/10.1182/blood.V122.21.4770.4770

Published: 2013

Journal Articles

A Comparison Of Hemostatic and Inflammatory Markers In Overt and Non-Overt DIC

Debra Hoppensteadt, Ph.D., Kazuhisa Tsuruta, Ph.D., Joe Hirman, Ph.D., Inder Kaul, MD, MPH, Yutaka Osawa, M Pharm, Jawed Fareed, Ph.D.

Blood (2013) 122 (21): 3577.

https://doi.org/10.1182/blood.V122.21.3577.3577

Published: 2013

Journal Articles

Thrombotic Biomarker Profiling Of Plasma Samples From Patients Undergoing Bypass Surgery Using Protein Chip Array

Jeanine M. Walenga, PhD, Takefumi Matsuo, Keiko Wanaka, Josephine Cunanan, Debra Hoppensteadt, Ph.D., Jawed Fareed, Ph.D.

Blood (2013) 122 (21): 3579.

https://doi.org/10.1182/blood.V122.21.3579.3579

Published: 2013

Journal Articles

Dysregulation Of Thrombotic and Hemostatic Factors In End Stage Renal Disease

Vinod Bansal, MD, Debra Hoppensteadt, Ph.D., Syed Ahmed, Jawed Fareed, Ph.D.

Blood (2013) 122 (21): 4793.

https://doi.org/10.1182/blood.V122.21.4793.4793

Published: 2013

Journal Articles

Effect Of Dabigatran and Rivaroxiban On Thrombomodulin Mediated Activation Of Protein C and Thrombin Activated Fibrinolysis Inhibitor (TAFI). Potential Clinical Implications

Debra Hoppensteadt, Ph.D., Josephine Cunanan, MD, Bruce E. Lewis, MD, Jawed Fareed, Ph.D.

Blood (2013) 122 (21): 3641.

https://doi.org/10.1182/blood.V122.21.3641.3641

Published: 2013

Journal Articles

Prothrombinase Induced Clotting Time (PICT) and Commercially Available Diluted Russell's Viper Venom Times For The Monitoring Of New Oral Anticoagulants

Debra Hoppensteadt, Ph.D., Jeanine M. Walenga, PhD, Josephine Cunanan, Omer Iqbal, MD, Jawed Fareed, Ph.D.

Blood (2013) 122 (21): 3642.

https://doi.org/10.1182/blood.V122.21.3642.3642

Published: 2013

Journal Articles

Neutralization Of Hemorrhage Induced By Direct Factor Xa and Thrombin Inhibitors In a Rat Model

Walter Jeske, PhD, Vicki Escalante, BS, Brian McGuire, BS, Jeanine M. Walenga, PhD, Jawed Fareed, Ph.D., Mamdouh Bakhos, MD

Blood (2013) 122 (21): 3644.

https://doi.org/10.1182/blood.V122.21.3644.3644

Published: 2013

Journal Articles

Defibrotide Interaction With Newer Oral Anticoagulant and Antiplatelet Drugs

Jawed Fareed, Ph.D., Michael J Moorman, III, Walter Jeske, Ph.D., Debra Hoppensteadt, Ph.D.

Blood (2013) 122 (21): 4804.

https://doi.org/10.1182/blood.V122.21.4804.4804

Published: 2013

Journal Articles

Oral Anti-Factor Xa and Factor IIa Agent Mediated Inhibition Of Tissue-Factor Mediated Generation Of Thrombin In Prothrombin Complex Concentrates

Daneyal Syed, Debra Hoppensteadt, Ph.D., Daniel Kahn, Job Harenberg, Prof.,, Jawed Fareed, Ph.D.

Blood (2013) 122 (21): 4810.

https://doi.org/10.1182/blood.V122.21.4810.4810

Published: 2013

Journal Articles

Immune-Mediated Activation Of Coagulation In Patients With Stevens Johnson Syndrome/Toxic Epidermal Necrolysis

Omer Iqbal, MD, Daneyal Syed, Michael Mosier, MD, Julia Malalis, Christine Mata, Amy Lin, Nicole Mitchel, Schurahazard Abro, Debra Hoppensteadt, Ph.D., Jawed Fareed, Ph.D., Charles Bouchard

Blood (2013) 122 (21): 1117.

https://doi.org/10.1182/blood.V122.21.1117.1117

Published: 2013

Journal Articles

Relative Immunologic Potential of Bovine Prothrombin and Purified Thrombins

He Zhu, MD, Debra Ann Hoppensteadt, Ph.D., Rodger L. Bick, MD, PhD, Cafer Adiguzel, MD, Rakesh Wahi, MD, Jawed Fareed, Ph.D.

Blood (2008) 112 (11): 5463.

https://doi.org/10.1182/blood.V112.11.5463.5463

Published: 2008

Journal Articles

Increased Antithrombotic and Bleeding Effects of Contaminated Heparins; Hematological Implications

Evangelos Litinas, MD, Walter Jeske, Ph.D., Debra Hoppensteadt, Ph.D., Harry Messmore, MD, Jeanine M. Walenga, PhD, Jawed Fareed, Ph.D.

Blood (2008) 112 (11): 3021.

https://doi.org/10.1182/blood.V112.11.3021.3021

Published: 2008

Journal Articles

Defibrotide Augments the Anticoagulant Actions of Heparin and Low Molecular Weight Heparins

Jawed Fareed, Ph.D., Omer Iqbal, M.D., Debra Hoppensteadt, Ph.D., Cafer Adiguzel, M.D., Massimo Iacobelli, M.D., Jeanine M. Walenga, Ph.D.

Blood (2008) 112 (11): 4086.

https://doi.org/10.1182/blood.V112.11.4086.4086

Published: 2008

Journal Articles

AVE5026: A New Hemisynthetic Ultra Low Molecular Weight Heparin with Enriched Anti-Xa Activity and Enhanced Antithrombotic Activity for Management of Cancer Associated Thrombosis

Debra Hoppensteadt, Ph.D., Walter Jeske, Ph.D., Jeanine M. Walenga, PhD, Jawed Fareed, Ph.D.

Blood (2008) 112 (11): 4046.

https://doi.org/10.1182/blood.V112.11.4046.4046

Published: 2008

Journal Articles

Molecular and Functional Heterogeneity in Contaminants Isolated from Recalled Heparin. Impact on Anticoagulation and Potential Adverse Reactions

Jawed Fareed, Ph.D., Debra Hoppensteadt, Ph.D., Walter Jeske, Ph.D., Cafer Adiguzel, MD, Omer Iqbal, MD, Jeanine M. Walenga, PhD

Blood (2008) 112 (11): 4048.

https://doi.org/10.1182/blood.V112.11.4048.4048

Published: 2008

Journal Articles

Glanzmann’s Thrombasthenia Patients with No Mutations in Both the ITGA2B and ITGB3 Genes as Identified by Conformation Sensitive Gel Electrophoresis (CSGE)

Meganathan Kannan, PhD, Firdos Ahmad, M.Sc, Birendra K Yadav, M.Sc, Rajive Kumar, MD, Jawed Fareed, Ph.D., Renu Saxena, MD

Blood (2008) 112 (11): 1236.

https://doi.org/10.1182/blood.V112.11.1236.1236

Published: 2008

Journal Articles

Modulation of Platelet Function by Recombinant Thrombomodulin Hematologic Implications.

Cafer Adiguzel, MD, Omer Iqbal, M.D., Daniel Fareed, B.S., Debra Hoppensteadt, Ph.D., Walter Jeske, Ph.D., Michael Simmikannu, B.S., Jawed Fareed, Ph.D.

Blood (2007) 110 (11): 3898.

https://doi.org/10.1182/blood.V110.11.3898.3898

Published: 2007

Journal Articles

Suppression of Markers of Thrombin Generation and Inflammation in Patients Receiving Low Molecular Weight Heparin Compared to Unfractionated Heparin for TEE-Guided Cardioversion of Atrial Fibrillation.

Debra Hoppensteadt, PhD, Jawed Fareed, Ph.D., Allan Klein, Ph.D., Susan Jasper, Ph.D., Carolyn Apperson-Hansen, Ph.D., Elizabeth Lieber, Ph.D., William Katz, Ph.D., Joseph Malouf, Ph.D., Marcus Stoddard, Ph.D.

Blood (2007) 110 (11): 3621.

https://doi.org/10.1182/blood.V110.11.3621.3621

Published: 2007

NARROW

Increased Levels Of Tissue Factor, Adhesion Molecules, Nitric Oxide and Adiponectin In End Stage Renal Disease. A Complex Interplay

Effect Of Purified Poloxamer 188 and Various Dextrans On Erythrocyte Sedimentation Rate In Healthy Subjects and Patients With Sickle Cell Disease

Comparative Studies Of Purified Poloxamer 188 Using ClotBased and Viscoelastic Measurements Of Coagulation

A Comparison Of Hemostatic and Inflammatory Markers In Overt and Non-Overt DIC

Thrombotic Biomarker Profiling Of Plasma Samples From Patients Undergoing Bypass Surgery Using Protein Chip Array

Dysregulation Of Thrombotic and Hemostatic Factors In End Stage Renal Disease

Effect Of Dabigatran and Rivaroxiban On Thrombomodulin Mediated Activation Of Protein C and Thrombin Activated Fibrinolysis Inhibitor (TAFI). Potential Clinical Implications

Prothrombinase Induced Clotting Time (PICT) and Commercially Available Diluted Russell's Viper Venom Times For The Monitoring Of New Oral Anticoagulants

Neutralization Of Hemorrhage Induced By Direct Factor Xa and Thrombin Inhibitors In a Rat Model

Defibrotide Interaction With Newer Oral Anticoagulant and Antiplatelet Drugs

Oral Anti-Factor Xa and Factor IIa Agent Mediated Inhibition Of Tissue-Factor Mediated Generation Of Thrombin In Prothrombin Complex Concentrates

Immune-Mediated Activation Of Coagulation In Patients With Stevens Johnson Syndrome/Toxic Epidermal Necrolysis

Relative Immunologic Potential of Bovine Prothrombin and Purified Thrombins

Increased Antithrombotic and Bleeding Effects of Contaminated Heparins; Hematological Implications

Defibrotide Augments the Anticoagulant Actions of Heparin and Low Molecular Weight Heparins

AVE5026: A New Hemisynthetic Ultra Low Molecular Weight Heparin with Enriched Anti-Xa Activity and Enhanced Antithrombotic Activity for Management of Cancer Associated Thrombosis

Molecular and Functional Heterogeneity in Contaminants Isolated from Recalled Heparin. Impact on Anticoagulation and Potential Adverse Reactions

Glanzmann’s Thrombasthenia Patients with No Mutations in Both the ITGA2B and ITGB3 Genes as Identified by Conformation Sensitive Gel Electrophoresis (CSGE)

Modulation of Platelet Function by Recombinant Thrombomodulin Hematologic Implications.

Suppression of Markers of Thrombin Generation and Inflammation in Patients Receiving Low Molecular Weight Heparin Compared to Unfractionated Heparin for TEE-Guided Cardioversion of Atrial Fibrillation.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only